Table 2.
Age <45 years (n = 217), mean (s.d.) | Age 45–64 years (n = 823), mean (s.d.) | Age ≥65 years (n = 488), mean (s.d.) | P-value | |
---|---|---|---|---|
ESR | −7.2 (15.7) | −4.07 (16) | −6.82 (20.1) | 0.08 |
TJC28 | −3.81 (6.9) | −2.64 (6.9) | −2.41 (7.0) | 0.001 |
SJC28 | −2.61 (6.2) | −2.32 (5.5) | −2.01 (5.9) | 0.16 |
Physician global VAS | −13.4 (22.4) | −12.9 (20.8) | −11.4 (21.2) | 0.15 |
Patient global VAS | −8.34 (26.7) | −9.83 (27.8) | −7.39 (27.2) | 0.10 |
MHAQ | −0.09 (0.33) | −0.09 (0.38) | −0.05 (0.38) | 0.02 |
CDAI | −8.57 (14.2) | −7.22 (13.1) | −5.93 (13.5) | 0.003 |
CDAI remission, % | 19.82 | 13 | 11.27 | 0.01 |
CDAI category | 0.045 | |||
Improve, % | 57 | 50.7 | 44.42 | |
No change, % | 33.33 | 38.75 | 43.05 | |
Worsen, % | 9.66 | 10.55 | 12.53 | |
Time baseline to follow-up, months | 7.32 (3.6) | 7.35 (3.5) | 7.66 (3.9) | 0.08 |